Ginkgolide B Linked to Longer and Healthier Lifespan in Aging Mice

In this study, researchers explored whether Ginkgolide B (GB), a natural compound extracted from the leaves of Ginkgo biloba, could influence the biology of aging. While Ginkgo biloba has long been used in traditional medicine and is commonly associated with cognitive support, its broader systemic effects on aging remain poorly understood. Rather than testing GB as a short-term supplement, the researchers administered it to female mice beginning at 20 months of age, roughly equivalent to late middle age in humans, and continued treatment throughout their remaining lifespan. 

The results were striking, not because they suggested a dramatic reversal of aging, but because they demonstrated steady preservation of function. Mice receiving Ginkgolide B lived longer than untreated mice, but more importantly, they maintained better physical performance. Grip strength remained stronger, coordination declined more slowly, and muscle contraction performance was preserved. Body composition also improved, with lower fat accumulation and higher lean mass, even though food intake remained unchanged. These findings suggest that GB helped maintain metabolic balance during aging. 

Beyond physical strength, the researchers examined biological markers associated with aging. Chronic inflammation, often called “inflammaging,” gradually worsens over time and contributes to tissue decline. GB-treated mice showed reduced levels of inflammatory markers and fewer senescent cells, which no longer divide but release signals that disrupt surrounding tissues. At the molecular level, advanced gene analysis revealed that GB shifted muscle cell gene expression patterns toward a more youthful profile. In particular, it reduced specific types of muscle cell nuclei associated with age-related degeneration. The compound appeared to influence microRNA-regulated pathways that govern cell survival and stress responses,. This analysis also revealed a previously unknown control pathway that regulates when muscle cells enter an aging state, suggesting a coordinated biological effect rather than a single-target intervention. 

Another notable finding was a reduction in tumor incidence among treated mice. While the study was not designed as a cancer-therapy trial, this observation suggests that maintaining systemic balance during aging may also reduce vulnerability to age-related diseases. 

What makes this research distinctive is its emphasis on maintaining resilience rather than aggressively altering lifespan pathways. Instead of attempting to “reverse aging,” Ginkgolide B appears to support biological stability, helping muscles, metabolism, and immune responses remain balanced as organisms grow older. Furthermore, by uncovering a previously unrecognized control pathway that influences when muscle cells enter an aging state, the study provides new insight into how muscle decline develops over time and highlights a potential target for future strategies aimed at preserving muscle health during aging. 

Although these findings are limited to female mice and require further validation in human studies, they contribute to a growing scientific understanding that aging is not a fixed trajectory. If future research confirms similar effects in humans, interventions inspired by this work may one day help people remain active and independent for longer, reducing healthcare burdens associated with frailty and age-related disease. In an aging global society, strategies that extend not only years but vitality may have a meaningful impact on individuals, families, and healthcare systems alike.